363 related articles for article (PubMed ID: 18941183)
1. IL-23 promotes maintenance but not commitment to the Th17 lineage.
Stritesky GL; Yeh N; Kaplan MH
J Immunol; 2008 Nov; 181(9):5948-55. PubMed ID: 18941183
[TBL] [Abstract][Full Text] [Related]
2. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
Guo Z; Zheng C; Chen Z; Gu D; Du W; Ge J; Han Z; Yang R
Eur J Immunol; 2009 Oct; 39(10):2840-9. PubMed ID: 19637224
[TBL] [Abstract][Full Text] [Related]
3. Microbial lipopeptides induce the production of IL-17 in Th cells.
Infante-Duarte C; Horton HF; Byrne MC; Kamradt T
J Immunol; 2000 Dec; 165(11):6107-15. PubMed ID: 11086043
[TBL] [Abstract][Full Text] [Related]
4. In vitro differentiation of dendritic cells in the presence of prostaglandin E2 alters the IL-12/IL-23 balance and promotes differentiation of Th17 cells.
Khayrullina T; Yen JH; Jing H; Ganea D
J Immunol; 2008 Jul; 181(1):721-35. PubMed ID: 18566439
[TBL] [Abstract][Full Text] [Related]
5. The IL-12/IL-23 axis and its role in Th17 cell development, pathology and plasticity in arthritis.
Cornelissen F; van Hamburg JP; Lubberts E
Curr Opin Investig Drugs; 2009 May; 10(5):452-62. PubMed ID: 19431078
[TBL] [Abstract][Full Text] [Related]
6. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state.
Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T
Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959
[TBL] [Abstract][Full Text] [Related]
7. IL-27 blocks RORc expression to inhibit lineage commitment of Th17 cells.
Diveu C; McGeachy MJ; Boniface K; Stumhofer JS; Sathe M; Joyce-Shaikh B; Chen Y; Tato CM; McClanahan TK; de Waal Malefyt R; Hunter CA; Cua DJ; Kastelein RA
J Immunol; 2009 May; 182(9):5748-56. PubMed ID: 19380822
[TBL] [Abstract][Full Text] [Related]
8. The receptor SIGIRR suppresses Th17 cell proliferation via inhibition of the interleukin-1 receptor pathway and mTOR kinase activation.
Gulen MF; Kang Z; Bulek K; Youzhong W; Kim TW; Chen Y; Altuntas CZ; Sass Bak-Jensen K; McGeachy MJ; Do JS; Xiao H; Delgoffe GM; Min B; Powell JD; Tuohy VK; Cua DJ; Li X
Immunity; 2010 Jan; 32(1):54-66. PubMed ID: 20060329
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17.
Nakae S; Iwakura Y; Suto H; Galli SJ
J Leukoc Biol; 2007 May; 81(5):1258-68. PubMed ID: 17307864
[TBL] [Abstract][Full Text] [Related]
10. Th17 cell differentiation: the long and winding road.
McGeachy MJ; Cua DJ
Immunity; 2008 Apr; 28(4):445-53. PubMed ID: 18400187
[TBL] [Abstract][Full Text] [Related]
11. Suppressors of cytokine signaling proteins are differentially expressed in Th1 and Th2 cells: implications for Th cell lineage commitment and maintenance.
Egwuagu CE; Yu CR; Zhang M; Mahdi RM; Kim SJ; Gery I
J Immunol; 2002 Apr; 168(7):3181-7. PubMed ID: 11907070
[TBL] [Abstract][Full Text] [Related]
12. Cutting edge: in vitro generated Th17 cells maintain their cytokine expression program in normal but not lymphopenic hosts.
Nurieva R; Yang XO; Chung Y; Dong C
J Immunol; 2009 Mar; 182(5):2565-8. PubMed ID: 19234148
[TBL] [Abstract][Full Text] [Related]
13. Cutting edge: vasoactive intestinal peptide (VIP) induces differentiation of Th17 cells with a distinctive cytokine profile.
Yadav M; Rosenbaum J; Goetzl EJ
J Immunol; 2008 Mar; 180(5):2772-6. PubMed ID: 18292497
[TBL] [Abstract][Full Text] [Related]
14. Invariant NKT cells inhibit development of the Th17 lineage.
Mars LT; Araujo L; Kerschen P; Diem S; Bourgeois E; Van LP; Carrié N; Dy M; Liblau RS; Herbelin A
Proc Natl Acad Sci U S A; 2009 Apr; 106(15):6238-43. PubMed ID: 19325124
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity and resistance to regulation by IL-4 during Th17 maturation.
Cooney LA; Towery K; Endres J; Fox DA
J Immunol; 2011 Nov; 187(9):4440-50. PubMed ID: 21949021
[TBL] [Abstract][Full Text] [Related]
16. Altered Th1 cell differentiation programming by CIITA deficiency.
Patel DR; Kaplan MH; Chang CH
J Immunol; 2004 Nov; 173(9):5501-8. PubMed ID: 15494498
[TBL] [Abstract][Full Text] [Related]
17. Development, cytokine profile and function of human interleukin 17-producing helper T cells.
Wilson NJ; Boniface K; Chan JR; McKenzie BS; Blumenschein WM; Mattson JD; Basham B; Smith K; Chen T; Morel F; Lecron JC; Kastelein RA; Cua DJ; McClanahan TK; Bowman EP; de Waal Malefyt R
Nat Immunol; 2007 Sep; 8(9):950-7. PubMed ID: 17676044
[TBL] [Abstract][Full Text] [Related]
18. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells.
Jones GW; McLoughlin RM; Hammond VJ; Parker CR; Williams JD; Malhotra R; Scheller J; Williams AS; Rose-John S; Topley N; Jones SA
J Immunol; 2010 Feb; 184(4):2130-9. PubMed ID: 20083667
[TBL] [Abstract][Full Text] [Related]
19. Targeting the development and effector functions of TH17 cells.
Ghilardi N; Ouyang W
Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530
[TBL] [Abstract][Full Text] [Related]
20. Th memory for interleukin-17 expression is stable in vivo.
Lexberg MH; Taubner A; Förster A; Albrecht I; Richter A; Kamradt T; Radbruch A; Chang HD
Eur J Immunol; 2008 Oct; 38(10):2654-64. PubMed ID: 18825747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
